Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.55
+1.54 (19.23%)
At close: Mar 9, 2026, 4:00 PM EDT
9.50
-0.05 (-0.52%)
After-hours: Mar 9, 2026, 7:54 PM EDT
CRBP Market Cap
CRBP has a market cap or net worth of $176.95 million as of March 9, 2026. Its market cap has increased by 75.54% in one year.
Market Cap
176.95M
Enterprise Value
15.31M
1-Year Change
75.54%
Ranking
Category
Stock Price
$9.55
Market Cap Chart
Since November 11, 2014, CRBP's market cap has increased from $75.80M to $176.95M, an increase of 133.44%. That is a compound annual growth rate of 7.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 140.60M | -1.61% |
| Dec 31, 2025 | 142.90M | -0.56% |
| Dec 31, 2024 | 143.70M | 438.20% |
| Dec 29, 2023 | 26.70M | 93.48% |
| Dec 30, 2022 | 13.80M | -82.10% |
| Dec 31, 2021 | 77.10M | -26.57% |
| Dec 31, 2020 | 105.00M | -70.26% |
| Dec 31, 2019 | 353.10M | 5.62% |
| Dec 31, 2018 | 334.30M | -14.19% |
| Dec 29, 2017 | 389.60M | 3.75% |
| Dec 30, 2016 | 375.50M | 505.65% |
| Dec 31, 2015 | 62.00M | -19.58% |
| Dec 31, 2014 | 77.10M | 1.72% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Pharmaceuticals | 160.50M |
| Immunic | 160.47M |
| Rani Therapeutics Holdings | 157.98M |
| Fate Therapeutics | 154.63M |
| Innate Pharma | 151.10M |
| Zentalis Pharmaceuticals | 148.60M |
| Unicycive Therapeutics | 141.63M |
| MacroGenics | 141.07M |